Newsletter | November 10, 2020

11.10.20 -- 4 Ways To Avoid Failure In Phase III Clinical Manufacturing

Industry Insights
4 Ways To Avoid Failure In Phase III Clinical Manufacturing

Understanding the challenges in the biopharma space is critical, as the planning you do today dictates the options you have later when the costs — and the stakes — get even higher.

7 Tips For Purchasing Your Next Cell Sorter

This article shares some tips to help you avoid buyer’s remorse and make an educated decision about which instrument to purchase. These tips provide you with the tools to make an informed decision when purchasing a cell sorter.

Mechanistic Modeling Of Chromatography To Speed Up Process Development

Catch up on the current opportunities and challenges for using mechanistic modeling to simulate and predict chromatographic behavior and experiments in silico

Converting From ELISA To Biacore SPR Assays

This article provides general guidance on how to convert an existing ELISA assay to a Biacore SPR-assay and, by doing so, shows how you can get results in less than half the time compared with ELISA.

8 Criteria For A More Successful API Partnership

Save time and money by addressing these eight critical areas that are required for a fast, smooth API development process.

Why Are Lipid Formulations Commonly Used To Enhance Bioavailability?

A discussion on potential mechanisms of increased absorption with lipid formulations, screening tools used during the development of these formulations, scale up, and industrialization considerations. 

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.